Remove BMI Remove Research Remove Strokes
article thumbnail

The association between the systemic immune-inflammation index and in-hospital mortality among acute ischemic stroke with atrial fibrillation patients undergoing intravenous thrombolysis

Frontiers in Cardiovascular Medicine

Two sensitivity analyses confirmed the robustness of this association from multiple perspectives (P<0.05). ROC analysis demonstrated that the SII, the baseline model, and their combined model all showed strong predictive power for in-hospital mortality.

article thumbnail

Research highlights disparities in heart disease, stroke trends worldwide

Medical Xpress - Cardiology

Incidence of stroke and ischemic heart disease are declining around the world, except for in a handful of regions, according to research in PLOS Global Public Health.

article thumbnail

Effects of weight loss after sleeve gastrectomy on left ventricular myocardial work in obese patients

Frontiers in Cardiovascular Medicine

Clinical information, parameters from left ventricular myocardial work and traditional two - dimensional strain echocardiography were collected and analyzed.ResultsAfter LSG, significant reductions in body mass index (BMI), diastolic blood pressure (DBP) and weight were observed.

Obesity 52
article thumbnail

The factors behind the shifting trends of ischemic heart disease and stroke

Science Daily - Heart Disease

Incidence of stroke and ischemic heart disease are declining around the world, except for in a handful of regions, according to a new study.

article thumbnail

Microplastics, Nanoplastics, and Major Cardiac Events

CardiacWire

fold greater risk of heart attack, stroke, or death within three years. The researchers examined carotid plaque specimens from 257 patients with asymptomatic carotid artery disease, analyzing their plaque for the presence of 11 MNPs, and tracking the patients’ cardiovascular outcomes over 34 months. An alarming 58.4%

Plaque 119
article thumbnail

Study Demonstrates Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age, Bleeding Risk

DAIC

In addition, abelacimab consistently reduced bleeding risk in patients 75 years of age and older regardless of renal function, body mass index (BMI), and the use of concomitant antiplatelet therapy. The ARR in patients 75 years of age and older was 6.2% compared to 4.2% in patients less than 75 years. in the low-risk category to 7.1%

article thumbnail

Global Trends in Cardiovascular Diseases: Insights from the 2023 Almanac

Cardiology Update

Major Trends in Global CVD and Risks The 2023 Almanac presents crucial insights into the Global Burden of Disease (GBD) for the period 1990-2022, revealing five major trends in global cardiovascular diseases (CVD) and associated risks, each with profound implications for clinical practice and research. in High-Income Asia Pacific to 432.3